AARTI DRUGS LTD. - 524348 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015
We wish to inform you that US FDA has inspected the Formulation (Oncology) manufacturing facility of our Subsidiary (Pinnacle Life Science Private Limited) at Baddi, Himachal Pradesh AARTI DRUGS LTD. - 524348 - Certificate As Per Regulation 40(9) And 40(10) Of SEBI (LODR) Regulations, 2015
Certificate as per Regulation 40(9) and 40(10) of SEBI (LODR) Regulations, 2015 AARTI DRUGS LTD. - 524348 - Compliance Certificate Pursuant To Regulation 7(3) Read With Regulation 7(2) Of The SEBI (LODR) Regulations, 2015 For The Financial Year Ended March 31, 2024.
Compliance Certificate pursuant to Regulation 7(3) read with Regulation 7(2) of SEBI (LODR) Regulations, 2015 for the financial year ended March 31, 2024 AARTI DRUGS LTD. - 524348 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of loss of share certificate AARTI DRUGS LTD. - 524348 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2024 AARTI DRUGS LTD. - 524348 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Issuance of letter of confirmation in liue of duplicate share certificate AARTI DRUGS LTD. - 524348 - Appointment Of Independent Directors
Appointment of Independent Directors AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Retirement
Retiremenet of Independent Directors
Open Account
